Market News & Trends
Thermo Fisher Scientific & SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions
Thermo Fisher Scientific Inc. recently announced a strategic collaboration with SHL Medical, a leading provider of advanced drug delivery systems, alongside an expansion of sterile…
Optibrium Introduces Graphical Interface for QuanSA to Enhance Ligand-Based Affinity Predictions
Optibrium recently announced a new QuanSA plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of…
Quotient Therapeutics Announces Collaboration With Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year research collaboration agreement with Merck, known…
Karyopharm’s Phase 3 in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction
Karyopharm Therapeutics Inc. recently reported topline results from its Phase 3 SENTRY trial, a randomized, double-blind, placebo-controlled trial of 60 mg selinexor in combination with…
ImmuneBridge Announces New Partnership Focus, Investment & CEO
ImmuneBridge recently announced it will make its platform available to partners – ranging from small biotech startups to established pharmaceutical companies. Therapeutic co-development partners will…
iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids
iXCells Biotechnologies recently announced it has entered an international collaboration with Rosebud Biosciences, Kantify, and Incite to evaluate off-target chemotherapeutic toxicities in patient-specific organoids. Building…
Perceptive eClinical & Kayentis Partner to Tackle Increasing Digital System Complexity in Global Clinical Trials
Perceptive eClinical and Kayentis recently announced a strategic alliance to deliver a fully integrated best-of-breed eCOA–IRT solution for clinical trials, one that offers sponsors and…
Nanexa Demonstrates Feasibility of Quarterly Semaglutide Dosing with PharmaShell
Nanexa AB recently announced highly promising new results from its long‑acting semaglutide program, developed using the company’s proprietary PharmaShell drug delivery platform. Building on the…
Clariant Expands Pharmaceutical-Grade PEG Manufacturing Into North America With Texas facility
Clariant is expanding its Clear Lake site to include excipient GMP-compliant manufacturing of pharmaceutical-grade polyethylene glycol (PEG) excipients, significantly improving their availability and reliability for…
Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics
Basecamp Research recently announced the launch of the Trillion Gene Atlas, a landmark scientific initiative to generate and model biological data at the trillion-gene scale.…
One-carbon Therapeutics Signs Strategic Collaboration With Tempus to Advance Molecular Insights & Enable Precision Oncology Development of TH9619
One-carbon Therapeutics recently announced a strategic collaboration with Tempus AI Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine.…
Green Light for First-in-Human Trial of KMCAR T-cell Therapy in Multiple Myeloma
HaemaLogiX Ltd and Peter MacCallum Cancer Centre (Peter Mac) are delighted to announce the achievement of a landmark regulatory milestone: receipt of Clinical Trial Approval…
Vetter Des Plaines Facility is the German American Chamber of Commerce’s Investment of the Year
The German American Chamber of Commerce awarded Vetter, a globally operating pharmaceutical service provider, the Investment of the Year Award 2026. The award was officially…
Neuland to Open Commercial Peptide Facility as part of Planned Phased Expansion
Neuland Laboratories will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with further capacity expansions planned…
Lonza & Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO
-Extended agreement will expand manufacturing capacity at Lonza Houston (US) to support growing demand for Genetix’s ZYNTEGLO (betibeglogene autotemcel), the only FDA-approved gene therapy for…
Centauri Therapeutics Granted FDA QIDP Status for CTX-187 Treatment of Gram-Negative Bacterial Infections
Centauri Therapeutics Limited recently announced the its lead clinical candidate in the ABX-01 program, CTX-187, has received Qualified Infectious Disease Product (QIDP) designation from the…
Upperton Submits MHRA License Application for Annex 1 Sterile Manufacturing Facility Following APS Validation
Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. ft sterile…
Biologos Appoints New CEO, Celebrates 50 Years of Growth & Innovation
Biologos recently announced the appointment of Hetal Patel as Chief Executive Officer.
Medicus Pharma Reports Positive Phase 2 Topline Data Observing 73% Clinical Clearance & 40% Histological Clearance
Medicus Pharma Ltd. recently announced topline results from its Phase 2 clinical study (SKNJCT-003) evaluating safety and efficacy of Doxorubicin Microneedle Array (D-MNA) to non-invasively…
LabVantage Solutions Introduces LabVantage CORTEX, Advancing its LIMS Platform for AI-Driven Laboratory Operations
LabVantage Solutions, Inc. recently announced the launch of LabVantage CORTEX, a next-generation artificial intelligence (AI), analytics, and automation platform. The launch represents a strategic evolution…
